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Abstract
Background: Cathepsin D is a well-characterized aspartic protease expressed ubiquitously in
lysosomes. Cathepsin D deficiency is associated with a spectrum of pathologies leading ultimately
to death. Cathepsin D is expressed at high levels in many cells of the immune system, but its role
in immune function is not well understood. This study examines the reconstitution and function of
the immune system in the absence of cathepsin D, using bone marrow radiation chimaeras in which
all haematopoietic cells are derived from cathepsin D deficient mice.
Results: Cathepsin D deficient bone marrow cells fully reconstitute the major cellular components
of both the adaptive and innate immune systems. Spleen cells from cathepsin D deficient chimaeric
mice contained an increased number of autofluorescent granules characteristic of lipofuscin
positive lysosomal storage diseases. Biochemical and ultrastructural changes in cathepsin D
deficient spleen are consistent with increased autolysosomal activity. Chimaeric mice were
immunised with either soluble (dinitrophenylated bovine gamma globulin) or particulate (sheep red
blood cells) antigens. Both antigens induced equivalent immune responses in wild type or cathepsin
D deficient chimaeras.
Conclusion: All the parameters of haematopoietic reconstitution and adaptive immunity which
were measured in this study were found to be normal in the absence of cathepsin D, even though
cathepsin D deficiency leads to dysregulation of lysosomal function.
Background
Cathepsin D, the first cathepsin to be identified, is an
aspartic proteinase which is ubiquitously expressed in lys-
osomes of most eukaryotic cells. The enzyme's highly con-
served sequence, and the fact that it is found in all
eukaryotic organisms examined, suggests it plays an
important role in cellular physiology, but its precise func-
tion is still poorly defined. The enzyme has a broad sub-
strate specificity at acidic pH and was long thought to
function in bulk degradative proteolysis of endocytosed
or phagocytosed material. Raised cathepsin D levels are
associated with metastatic potential in some cancers [1],
perhaps reflecting the increased metabolism of these cells,
or perhaps due to a role in extracellular matrix degrada-
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tion. Cathepsin D has also been implicated in cell growth
and apoptosis, though it remains unclear whether these
functions require the proteolytic activity of the enzyme, or
involve some separate ligand/receptor interaction [2].
In order to probe the role of cathepsin D further, a cathe-
psin D deficient mouse was previously generated by
homologous recombination [3]. Cathepsin D deficiency
conferred a lethal phenotype, with mice dying around
days 21–22. The mice suffered severe weight loss, as well
as neurological abnormalities including seizures and
blindness. Histopathological investigation showed exten-
sive atrophy of the digestive system, which is probably
responsible for weight loss and death. The mice also
showed profound atrophy of lymphoid tissue such as thy-
mus and spleen. The precise link between cathepsin D
deficiency and pathology remains unclear, but bulk prote-
olysis by cathepsin D deficient fibroblasts was found to be
normal.
More recently, attention has shifted to the role of cathep-
sin D in neuronal tissues. As indicated above, cathepsin D
deficient mice exhibit various neurological abnormalities,
and these have been related to neuronal degeneration
[4,5] associated with the development of lipofuscin con-
taining granules, characteristic of a class of lysosomal stor-
age diseases. The link between cathepsin D deficiency,
lipofuscin containing granules (which may represent
abnormal autophagic vacuoles) and neurological dys-
function has now been observed in several other species
including Drosophila [6], sheep [7], dogs [8] and man
[9,10]. The specific target of cathepsin D which is respon-
sible for these pathologies remains unidentified, but the
action of cathepsin D could be indirect via activation of a
proenzyme. For example, cathepsin D has been proposed
to play a role in epidermal differentiation via regulation of
transglutaminase 1 activation [11].
There have been numerous suggestions that cathepsin D
plays a role in cells of the immune system. Early studies
proposed a role in antigen processing for the class II MHC
endocytic pathway [12]. However, many of these studies
have used the microbial proteinase inhibitor pepstatin to
block cathepsin D. Interpretation of these experiments is
difficult because pepstatin also blocks cathepsin E, a sec-
ond non-lysosomal aspartic proteinase found in many
cells of the immune system. More definitive in vitro stud-
ies using cathepsin D deficient mouse spleen cells sug-
gested that this enzyme was dispensable for antigen
processing/presentation [13]. More recent studies which
combined pharmacological inhibition with the use of the
cathepsin D deficient mice suggest that cathepsin E, rather
than cathepsin D, is the major aspartic proteinase active in
the antigen processing pathway [14]. Cathepsin D may
also play a role in limiting antigen processing by destruc-
tion of antigen epitopes [15].
The function of cathepsin D in the development and func-
tion of the immune system remains unclear, since the
multiple abnormalities and ultimate lethality seen in the
enzyme deficient mice both limit the extent of immuno-
logical investigations, and complicate the interpretation
of in vivo phenotypes. In this study, mice which selec-
tively lack cathepsin D in cells of haematopoietic origin
are generated by making bone marrow radiation chimae-
ras. This model is used to test the hypothesis that cathep-
sin D plays a non-redundant role in lysosomal function in
immune cells, and examines the importance of this dur-
ing development and function of the major branches of
the adaptive immune system in vivo.
Results
Irradiated mice which received bone marrow from either
wild type or cathepsin D deficient mice all survived, while
control irradiated mice which did not receive bone mar-
row all died. Full reconstitution as measured by blood T
cell and B cell counts took two-three months, and blood
leukocytes of chimaeras were routinely phenotyped by
flow cytometry before use in experiments. No significant
differences in numbers of T cells or B cells (fig 1a) or gran-
ulocytes (not shown) were observed between unirradiated
control mice, or chimaeras generated from bone marrow
taken from cathepsin D deficient (CCDD) or cathepsin D
wild type (CCDWT) mice. The levels of cathepsin D in tis-
sues collected from chimaeras were measured by Western
blot (fig 1b). The antibody detects both the proenzyme
(53KD) and mature single chain (48kD) enzyme (note
two bands in fig 1b). Levels of cathepsin D (both proen-
zyme and mature) in spleen of CCDD chimaeras were less
than 10% of those found in spleens of CCDWT chimae-
ras, confirming that most or all the spleen haematopoietic
cells were derived from donor precursors, and did not rep-
resent the selective outgrowth of a small minority of sur-
viving host precursor cells. In order to confirm that equal
amounts of protein were present in both samples, the
membranes were reprobed for cathepsin E, which was
present in equal amounts in CCDD and CDDWT spleens
(fig 1b). In contrast, levels of cathepsin D in liver, which
is composed predominantly of non-haematopoietic tis-
sue, were equivalent in both sets of chimaeras (fig 1b, bot-
tom panel). Western blot of liver showed a single band
corresponding to mature cathepsin D, suggesting that, in
contrast to spleen, little proenzyme was stored in cells of
this tissue.
Since spleen contains non-haematopoietic cells which
may contribute to the remaining signal seen in Fig 1b den-
dritic cells were cultured from bone marrow of chimaeras
and stained for cathepsin D expression by immunofluo-BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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rescence (fig 1c). Over 80% of the dendritic cells from
CCDWT chimaeras showed strong positive lysosomal
staining with cathepsin D antibody, while in contrast, less
than 0.1% of CCDD cells showed any staining. Spleen
morphology in CCDWT and CCDD chimaeras was indis-
tinguishable (fig 1d) (although chimaeric spleens were
always smaller than unirradiated age matched control
spleens), and there was no evidence of the extensive atro-
phy seen in the cathepsin D deficient donor mice imme-
diately prior to death [3]. Intestinal morphology was also
normal (fig 1e), and no atrophy was observed in chimae-
ras. These results suggest that the defect in intestinal devel-
opment observed in cathepsin D deficient mice is an
autonomous defect in intestinal cell function, rather than
a consequence of haematopoietic dysfunction. In con-
trast, lymphoid tissue atrophy observed in cathepsin D
Expression of cathepsin D and tissue histology in cathepsin D chimaeric mice Figure 1
Expression of cathepsin D and tissue histology in cathepsin D chimaeric mice. a) Leukocytes cells were collected 
from control unirradiated mice (Balb/c), or from CCDWT or CCDD between 8 and 12 weeks post reconstitution, and stained 
for CD3 (T cells) or B220 (B cells). The results show the average % of each cell type, from a minimum of 5 different experi-
ments, with standard error of mean. No significant differences (Student's T Test) were observed between any of the three 
groups of mice. b) Spleens and livers were collected from CCDWT and CCDD mice three-four months post reconstitution, 
and analysed for cathepsin D and cathepsin E expression by Western blot. The blot for spleen shows the presence of precur-
sor (53KD) and single chain (48KD) forms of cathepsin D. The two single chain degradation products of 31 and 14KD are not 
shown in this figure. Left panel shows a representative example from one individual mouse from each group. Right panel shows 
the mean band density (and standard error of the mean) for cathepsin D staining for spleen extracts from five mice taken from 
three independent experiments. c) Dendritic cells were cultured from bone marrow of CCDWT and CCDD mice, and stained 
for cathepsin D expression by immunofluorescence. Nuclei are stained with DAPI. At least 100 cells per slide were scored as 
cathepsin D positive or negative from each sample. The % cells showing cathepsin D staining was greater than 80% for 
CCDWT, and less than 1% for CCDD mice. d) Spleen from CCDD and CCDWT mice was collected and standard haematox-
ylin and eosin staining was performed on 4 µm sections of formalin-fixed paraffin embedded tissues. A. Low power view of 
CCDWT mouse spleen. B. High power view of CCDWT spleen showing PALS (periarteriolar lymphoid sheath) and adjacent 
red pulp. C. Low power view of CCDD mouse spleen. D. High power view of CCDD mouse spleen showing PALS and adja-
cent red pulp. e) Upper intestine from CCDD mice was collected and processed as for panel d. Longitudinal and transverse 
sections show the normal crypt morphology of the adsorptive epithelium.BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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deficient mice is a secondary effect, perhaps resulting from
gut dysfunction.
The cellular composition of lymphoid tissue and thymus
was examined in more detail, as shown in figs 2 and 3.
Spleen (and lymph nodes, not shown) of CCDWT and
CCDD mice contained normal proportions of B cells
(detected with B220 antibody), T cells (detected with CD3
antibody) and macrophages (double positive for CD11b
and F4/80) (figs 2a–d). The proportion of CD4 versus
CD8 cells, and the proportions of the various subpopula-
tions of myeloid dendritic cells (CD11c+, CD11b+ and
CD11b+) were also the same in CCDWT and CCDD (figs
2e, f). The proportion of granulocytes in blood and spleen
was also the same between experimental groups (not
shown). Finally, the proportion of CD3, CD4, CD8 and
double positive T cells in thymus was the same in Balb/c
recipients, CCDWT and CCDD animals (figs 3a–c), sug-
gesting T cell development was not affected by cathepsin
D deficiency. Thus, cathepsin D is dispensable for the nor-
mal development and differentiation of all the major cell
types of the immune system.
In the course of carrying out the flow cytometry studies
shown in figs 2 and 3, we noted that spleen cells, lymph
node cells and thymus cells from CCDD mice consistently
showed a small but significant increase in autofluores-
cence in the absence of any antibody (typically increase of
around 20% in background FL1, see fig 4a, p < 0.02, n =
5), which was observed in both FL1 and FL2 channels (fig
Flow cytometry of major spleen leukocyte populations in CCDWT and CCDD Figure 2
Flow cytometry of major spleen leukocyte populations in CCDWT and CCDD. Spleen cells were collected from 
chimaeras at least three months post-reconstitution, and stained for various lineage markers as described in Materials and 
Methods. One representative staining of at least 6 separate experiments on different mice of each chimaera type is shown. The 
% of cells staining for each type is shown above the marker (histograms), in each quadrant (e) or in the gate shown (d, f). An 
example of isotype control staining is shown in right column of panel d. a) Forward/side scatter plot for spleen cells showing 
normal distribution of size/granularity in both CCDWT and CCDD. Gate shows region analysed for plots b-f b) Single colour 
staining for B cells with anti-B220 antibody. c) Single colour staining for T cells with anti-CD3 antibody. d) Two colour staining 
for macrophages using anti-F4/80 and antibody anti-CD11b. e) Two colour staining with anti-CD4 and anti-CD8 antibodies. f) 
Two colour staining for dendritic cells with anti-CD11b and anti-CD11c antibodies.BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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4b). Since increased autofluorescence is characteristic of
the lipofuscin deposits previously noted in cathepsin D
deficient neurones [16], we examined this phenomenon
further. Cytospin preparations of spleen cells from chi-
maeric mice were examined by confocal microscopy (figs
4c–f). Cells from CCDD mice were found to contain
strongly autofluorescent granules at a considerably higher
frequency than those of CCWT. The granules were of var-
ious sizes, and cells typically contained one or two gran-
ules only (fig 4d). The granules were found both in CD3
T cells (Fig 4e) and CD11b positive macrophages (Fig 4f),
but rarely in B cells (not shown). Spleen cells from the chi-
maeras were also examined by electron microscopy (fig
5a). Macrophages located in the marginal areas of the
white pulp from CCDD chimaeras contained many large
vacuoles with significant amounts of undigested sub-
stances. These structures resembled granular osmiophilic
deposits, typical of neuronal ceroid-lipofuscinosis
autophagic or autolyososomal bodies [17]. A biochemical
marker of autophagy is microtubule-associated protein 1
light chain 3 (LC3)[18]. Spleen cells from CCDD chimae-
ras showed increased levels of LC3 protein, as detected by
Western blot analysis (fig 5b). In contrast to the results
obtained in liver and brain [19], LC3 protein expression
in CCDWT was very low, and cathepsin D deficiency was
associated with increased expression of both light (LC3II,
membrane-bound) and heavy (LC3I, cytosolic) forms of
LC3. The proportion of membrane form was higher in the
CCDD spleen than that seen in control liver tissue (fig 5b,
left panel). As expected, no differences in LC3 expression
were observed between the livers of CCDD and CCDWT
(not shown). LC3 distribution was also investigated by
immunofluorescence. The LC3 antibody stained discrete
intracellular vesicles, consistent with an autophagosome
Flow cytometry of major T cell populations in CCDWT and CCDD thymus Figure 3
Flow cytometry of major T cell populations in CCDWT and CCDD thymus. Thymocytes were collected from chi-
maeras at least three months post-reconstitution, or a control age matched Balb/c mouse and stained for various lineage mark-
ers as described in Materials and Methods. a) Forward/side scatter plot for thymus cells showing normal distribution of size/
granularity in both CCDWT and CCDD. Gate shows region analysed for plots b. b) Single and double staining with anti-CD4 
and anti-CD8 antibodies. c) Single colour staining for T cells with anti-CD3 antibody. One representative staining of at least 5 
separate experiments on different mice of each chimaera type is shown. The % of cells staining for each type is shown in each 
quadrant.BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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distribution (fig 5c, left panel). LC3 staining was often
high in cells with autofluorescent granules (Fig 5c, right
panel), although since autofluorescence was visible in
both red and green channels, it was not possible to defin-
itively determine that LC3 was present in the autofluores-
cent granules themselves.
The functional integrity of the immune system from
cathepsin D deficient mice was then tested in vivo, using
two different antigen systems. The first was the antibody
response to DNP-Bovine gamma globulin (DNP-BIg), a
classical soluble T helper dependent antigen, adminis-
tered with alum adjuvant. Mice were immunised with a
range of concentrations (0.1–10 µg/ml) and antibody
response (IgM, and various IgG subclasses) was measured
after a primary and secondary challenge. Representative
examples of the data showing IgM responses after primary
immunisation, and IgG responses after secondary immu-
nisation, are shown in fig 6 (immunization with 6 µg is
shown, since this was the lowest concentration found to
Increase in autolysosomal (autophagic) vacuoles in CCDD spleen cells Figure 4
Increase in autolysosomal (autophagic) vacuoles in CCDD spleen cells. a) and b) Flow cytometry of unstained spleen 
cells from CCDWT and CCDD chimaeras. a) Average FL1 signal from five unstained preparation of spleen cells for CCDWT 
and CCDD. The average of CCDD is significantly greater than the CCDWT (Student's t-test two tailed, p < 0.02). b) Left pan-
els show forward and side scatter profiles, which are indistinguishable between the two experimental groups. Right panels 
show contour plots of FL1 and FL2 autofluorescence. Note the different shape of the CCDD plot, reflecting increased fluores-
cence in both FL1 and FL2 channels. c) Spleen cells from CCDWT (left) and CCDD (right) were adhered to poly L-lysine, and 
fixed as described. Images were collected by confocal laser microscopy. The top left panel shows nuclear staining with DAPI, 
acquired using the UV laser. The top right panel shows images acquired using the Argon laser (excitation 488) and the emission 
settings for FITC fluorescence. The bottom left panel shows images acquired using the Argon laser and the emission settings 
for PE fluorescence. The bottom right shows a merged image of the three other panels. Scale bar – 10 µM. d) High power view 
of cells from CCDWT and CCDD. Scale bar – 10 µM. e) As for d, but arrow shows T cell stained with anti-CD3 FITC, con-
taining autofluorescent granule. f) As for d, but arrow shows macrophage stained with anti-CD11b APC, containing autofluo-
rescent granules.BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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give reproducible responses for all isotypes tested). The
response did vary between individual mice. However,
both CCDWT and CCDD mice showed good responses as
shown. A two-way ANOVA on the data from all the ani-
mals showed that cathepsin D deficiency did not signifi-
cantly affect the antibody response for IgM and IgG1 at
the concentrations tested, but had a slight enhancing
effect on IgG2b (p = 0.03).
Since cathepsin D is a phagolysosomal enzyme, we rea-
soned that cathepsin D might play a more significant role
in responses to particulate antigens. Chimaeric mice were
therefore immunised with SRBC, and antibody responses
measured as before (fig 6b). Once again, both CCDWT
and CCDD chimaeras showed strong responses to the
antigen. Two-way ANOVA showed no significant effect of
cathepsin D deficiency on IgM, IgG1 or IgG2b (P > 0.05).
The T cell response to SRBC was assessed in parallel by
measuring IL-2 and IL-4 release by spleen cells from
immunised mice using ELISPOT (fig 7). No significant
interferon γ release was observed in any mice, reflecting
the known TH2 bias of the Balb/c strain. We observed no
significant differences between CCDWT and CCDD mice
for either IL-2 or IL-4 release (p > 0.2, Student's T-Test).
a) Electron microscope images of spleen cells from CCDD (A-C) and CCDWT (D) Figure 5
a) Electron microscope images of spleen cells from CCDD (A-C) and CCDWT (D). Macrophages (one example marked with 
asterisk in panel A) in the marginal region of the white pulp contain abundant lysosomal/vacuolar structures, most of which 
resemble granular osmiophilic deposits (B, a higher power of the quadrated area in A). Lymphocytes in the region appear intact 
(A). In the red pulp, such macrophages with abundant lysosomal structures (arrow) appear to be less in number (C). Macro-
phages (asterisk) and lymphocytes in the spleen of CCDWT show normal structures (D). b) Western blot showing expression 
of LC3 and cathepsin E (as loading control) in spleens from CCDWT and CCDD. A blot of CCDWT liver with LC3 antibody 
is shown for comparison. Arrows show the position of the soluble (LC3I – 18kD) and membrane bound (LC3II – 16kD) forms 
of LC3. c) Distribution of LC3 in spleen cells from CCDD (LC3 was not detectable above background in CCDWT). Left panel 
– LC3 staining. Right panel – autofluorescence. Note presence of high levels of LC3 in a cell with strong autofluorescent gran-
ules (arrow). Lower panels shows autofluorescent granules in controls, without primary antibody.BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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Discussion
Cathepsin D, consistent with its highly conserved
sequence and ubiquitous expression throughout the
eukaryotes, is an essential non-redundant enzyme. As well
as contributing to lysosomal proteolysis, the enzyme has
been implicated in the apoptotic signalling pathway
[20,21] and in regulation of cell proliferation [22]. Con-
sistent with such wider roles, previous studies have
reported extensive tissue pathology associated with cathe-
psin D deficiency. These have included abnormal gut
development [3], atrophy of primary and secondary lym-
phoid tissues [3] and most notably extensive neurodegen-
eration and neuronal cell death [23]. Previous studies,
however, have been limited to models of global, rather
than tissue specific cathepsin D deficiency. The ubiqui-
tous distribution of cathepsin D presents some difficulties
in the interpretation of such models. In particular, cell
damage may occur from a direct effect of absence of cathe-
psin D on that cell's function (intrinsic), or as a result of
secondary damage due to malfunction of other cells or
organs (extrinsic). This problem has been circumvented in
part by studying the function of specific cell types in vitro
[24,25], but this approach is limited in the mouse,
because animals carrying the cathepsin D deficiency are
non-viable after three weeks of age.
The use of bone marrow reconstitution to make chimaeras
is an alternative approach to study the intrinsic effects of
Antibody responses to soluble and particulate antigens in CCDWT and CCDD Figure 6
Antibody responses to soluble and particulate antigens in CCDWT and CCDD. a) ELISA from chimaeric mice 
immunised with 6 µg DNP-BIg/alum as described in the text. IgM responses were measured five days post priming; the highest 
concentration of plasma corresponds to a dilution of 1: 30. IgG1 and IgG 2b responses were measured six days post boost; the 
highest concentration of plasma corresponds to a dilution of 1: 100. Each point represents average and standard error of the 
mean of three mice. Preimmune sera all gave OD values of less than 0.2 at the highest concentration shown. b) ELISA from 
plasma of chimaeric mice immunised with SRBC (108 cells/mouse). IgM responses were measured five days post priming; the 
highest concentration of plasma corresponds to a dilution of 1: 300. IgG1 and IgG 2b responses were measured six days post 
boost; the highest concentration of plasma corresponds to a dilution of 1: 900. Each point represents average of at least six 
mice. Preimmune sera all gave OD values of less than 0.1 at the highest concentration shown.BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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cathepsin D deficiency on haemopoetic cell development
and function. In contrast to the results reported by Saftig
et al. [3], the lymphoid tissues of these mice reconstitute
normally, although we cannot rule out the possibility that
there are undetected abnormalities in eosinophils, meg-
akaryocytes or some other cell type we have not yet inves-
tigated. We conclude that the atrophy of lymphoid organs
reported previously is therefore a secondary defect, arising
perhaps from failure of the digestive system and gut atro-
phy. Cell recoveries of the major populations of lym-
phocytes and macrophages were also normal, suggesting
that the absence of the enzyme did not affect cellular
homeostasis. Consistent with these results, no major dif-
ferences in number of apoptotic cells was observed in the
cathepsin D deficient mice (data not shown). A recent
study has suggested that cathepsin D may mediate macro-
phage apoptosis in response to bacterial challenge [26].
Studies are in progress to investigate this phenomenon in
the chimaeric model.
Our studies have also suggested that the major branches
of the adaptive immune system function normally in the
absence of cathepsin D, although we cannot rule out that
abnormalities exist in innate immunity, or other parame-
ters of adaptive immunity not yet tested. These studies are
the first to investigate immune function in the absence of
cathepsin D in vivo. Previous studies on antigen process-
ing have demonstrated small or no effects on antigen
processing in vitro [27,28]. Further studies investigating
the adaptive immune response to intracellular pathogens
are in progress to explore whether cathepsin D may have
a more selective processing or even a direct microbicidal
role in control of such pathogens [29,30].
Numerous studies have reported a defect in autophagic
function in cells lacking cathepsin D [31]. In agreement
with these studies, we find an increased number of
autophagic vacuoles in the spleen cells of deficient mice.
However, in contrast to the neuronal models, this defect
appears to be of limited extent. Only a small proportion
of cells show the presence of autophagic vacuoles, and
there is no evidence that the defect leads to extensive cell
death. This may reflect a much greater sensitivity of neu-
ronal cells to the build up of undigested additional
enzyme redundancies in the cells of the immune system,
leaving them more able to cope with the absence of cathe-
psin D [32,33]. However, there is considerable current
interest in the role of autophagy in the antigen processing/
presenting pathway for endogenous antigens [34], and
the chimaeras described in this paper will provide a valu-
able model to see if cathepsin D has a specific role in this
pathway.
Conclusion
In this study, we describe a model in which the role of
cathepsin D in cells of the immune system can be exam-
ined in vivo, in the absence of secondary damage due to
malfunction of other tissues. These experiments clearly
demonstrate that the major cellular components of the
immune system can develop in the absence of endog-
enous cathepsin D, and that adaptive immunity to both
soluble and particulate antigens is broadly intact. Further
studies will be required to determine whether more subtle
inhibitory or enhancing effects of cathepsin D on T cell
dependent immune responses can be observed in vivo,
mirroring the effects noted in vitro [35,36].
The lymphoid tissue of these cathepsin D deficient chi-
maeras show evidence of the same lysosomal dysfunction
which has been shown to give rise to major malfunction
in the nervous system. The precise molecular link between
absence of cathepsin D and the development of autofluo-
rescent autolysosomal vesicles is still unknown, but it is
certainly possible that further, more detailed examination
of immune function in these chimaeras may yet identify
further specific defects in responses to particular patho-
gens. The model system described in this study will allow
the study of such defects to be extended from the in vitro
models used previously to in vivo studies in the context of
a functioning immune system.
Methods
Mice
Balb/c mice (Balb/c Ola Hsd) were purchased from Har-
lan UK and kept in the Biological Services, UCL. Mice car-
rying a neomycin insertion in the cathepsin D gene [3]
T cell responses to particulate antigen in CCDWT and  CCDD Figure 7
T cell responses to particulate antigen in CCDWT 
and CCDD. Spleen cells (1.2 × 106) from chimaeric mice 
from each experimental group immunised with SRBC (108 
cells/mouse) were cultured for eight hours in the presence of 
SRBC (4 × 105) and the number of cells secreting IL-2 or IL-4 
measured by ELISPOT. The results show mean and SEM 
number of spots from eight individual mice. Spleen cells from 
mice immunised with PBS only gave values of less than 10 
spots/well for IL-2 and less than 80 spots per well for IL-4.BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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were bred onto the Balb/c background for at least ten gen-
erations, and then maintained as a heterozygote inbred
colony. Homozygotes could be identified by day 19 or 20
by their small size, and reduced mobility. Genotype was
confirmed in each case by PCR as described [3]. All exper-
iments were carried out under UK Animal Project Licence
authorization.
Bone marrow radiation chimaeras
Recipient Balb/c mice were kept on acidified water
(0.01% conc. HCl in H20) for 1 week prior to transfer. The
mice were irradiated with 8 Gy (delivered over 15–30
minutes) with an X-ray source (A.G.O. HS X-RAY SYSTEM,
Reading, UK) and then allowed to recover for 4–5 hours,
before receiving 2 × 106 bone marrow cells from cathepsin
D deficient, or wild type litter mates, intravenously in 0.2
mls PBS. One control mouse received PBS in each experi-
ment. All these controls died within ten days of irradia-
tion. The chimaeric mice were maintained for a minimum
of 2–3 months in order to allow full reconstitution of the
immune system (see Results).
Dendritic cell culture
Mouse myeloid dendritic cells were obtained by culture of
bone marrow cells (5 × 105/ml) in Iscove's medium
(Gibco BRL (Invitrogen Life Technologies/Life Sciences),
Paisley, UK), 10% FCS (Gibco BRL) with the addition of
GM-CSF (20 ng/ml; PeproTech, Rocky Hill, NJ, USA).
Fresh medium and cytokine were added on day 4 and
dendritic cells were harvested on days 7/8. Dendritic cells
were further purified by magnetic cell sorting, using
mouse CD11c+ microbeads (CD11c (N418), Miltenyi Bio-
tec, Bergisch Gladbach, Germany) and the appropriate
columns (MS separation columns, Miltenyi Biotec),
according to the manufacture's guidelines. The enriched
population was 85–95% CD11c+.
Western blotting
Western blots were performed on liver or spleen homoge-
nate, prepared using a Dounce homoginiser. 30 µg pro-
tein (measured by Bradford assay) were loaded in each
lane and separated by 12% denaturing SDS polyacryla-
mide gel electrophoresis (PAGE) under reducing condi-
tions. Proteins were transferred electrophoretically to
nitrocellulose membranes and then immunostained
using standard procedures. Primary antibodies used were:
monoclonal rat anti-mouse Cathepsin D (R&D System,
Minneapolis, MN, US, 4 µg/ml); rabbit anti-rat Cathepsin
E antibody (WAKO, Neuss, Germany), diluted 1:1000;
rabbit anti-rat microtubule-associated protein 1 light
chain 3 (LC3) antibody, diluted 1:1000 [37]. Primary
antibodies were detected using HRP-conjugated rabbit
anti-rat IgG or swine anti-rabbit IgG (DAKO, Glostrup,
Denmark, diluted 1:2000), and ECL detection reagent
(Amersham Pharmacia Biotech, Bucks, UK). For quantifi-
cation, gels were scanned and digital images analyzed
using Image J software [38].
Immunofluorescence
Dendritic cells (5 × 104) or spleen cells prepared as
described above were allowed to adhere for 30 minutes on
poly L-lysine (Sigma Aldrich, Poole, UK, 100 µg/ml in
water) coated 18 mm circular cover slips. The cells were
fixed for 10 minutes in 4% paraformaldehyde, permeabi-
lised with 0.2% Triton-X for three minutes, and then
stained using standard protocols for indirect immunoflu-
orescence. Cathepsin D was detected with goat anti-
mouse Cathepsin D antibody (1:100, R&D), and rabbit
anti-goat FITC (DAKO). For detection of autofluorescent
granules (fig 5) spleen cells (105) were adhered to cover
slips as above and fixed with paraformaldehyde, with no
permeabilisation or further staining steps. For staining of
LC3 the spleen cells were fixed for 10 minutes in 4% para-
formaldehyde, permeabilised with 0.2% Triton-X for
three minutes, and then stained using standard protocols
for indirect immunofluorescence as above. Nuclei were
counterstained with 4'-6-Diamidino-2-phenylindole
(DAPI, 2 µg/ml) for ten minutes prior to mounting.
Histology and histochemistry
Standard haematoxylin and eosin staining was performed
on 4 µm sections of formalin-fixed paraffin embedded tis-
sues.
Flow cytometry
Cells were collected from spleen, thymus or lymph node
of bone marrow radiation chimaeras, and stained using
standard flow cytometry protocols. Fc receptor and non-
specific binding was blocked by incubation in PBS con-
taining 10% v/v rat serum (Gibco BRL) and 0.1% NaN3
for 45 min at room temperature. Primary antibodies used
were: control FITC IgG2b,κ, PharMingen, Temse, Belgium;
control PE IgG2b,κ Pharmingen (other isotypes were also
tested and gave identical profiles, not shown); B220-FITC
(CD45R) IgG2a,κ, PharMingen; CD3εFITC, IgG2b,κ,
PharMingen; CD4-PE IgG2a, Caltag Lab, Paisley, UK and/
or CD4APC (GK1.5) IgG2b,κ, PharMingen; CD8α/Ly-2-
PE, IgG2a,κ, eBioscience; CD11b-APC (M1/70) IgG2b,κ,
Biolegend; CD11c-PE (N418) IgG, eBioscience, Middle-
sex, UK; GR1-FITC (Ly-6C/G), IgG2b,κ, PharMingen; F4/
80-PE, IgG2a,κ, eBioscience. Optimum concentrations
were determined by titration. After staining, all samples
were fixed by adding 100 µl 3.7% v/v formaldehyde/
saline and stored at 4°C in the dark for analysis within 5
days on a FACScan (Becton-Dickinson, Mountain View,
CA, USA) using WinMDI (Joseph Trotter, Scripps Research
Institute, La Jolla, CA, USA or Cell Quest) software. For
each sample not less than 10000 events were acquired.BMC Immunology 2007, 8:22 http://www.biomedcentral.com/1471-2172/8/22
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Immunization of bone marrow radiation chimaeras
Preimmune plasma was collected by tail bleed of all mice
one day before immunization. Blood was collected in
heparin-coated tubes (Microvette® CB 300, Sarsted, Ger-
many), and plasma was separated by centrifugation for 10
minutes at 10000 g, and stored at -20°C (in some experi-
ments serum was collected instead of plasma, but results
were always similar). All preimmune samples were tested
in parallel to test samples, but were all found to give
responses similar to background (data not shown).
Mice were then immunised with dinitrophenylated
bovine Ig (DNP-BIg, [39]) or sheep red blood cells
(SRBC). Chimaeric mice or unirradiated Balb/c controls
were injected intraperitoneally with varying amounts of
DNP-IgG (see below) in 100 µl PBS mixed with 100 µl
adjuvant (Imject® Alum, Pierce, USA), or with 500 µl of 2
× 108 cell/ml SRBC suspension (TCS Biosciences, UK).
Plasma samples were collected 5/6 days after priming
(primary response), and stored as above. 2 weeks after
priming, the mice were boosted with the same amount of
antigen as used during the first injection. 6 days after the
boosting (secondary response), plasma was collected and
stored as above. Mice immunised with SRBC were then
sacrificed, and spleens collected for ELISPOT analysis as
described below. Controls were injected with PBS alone.
ELISA
DNP-IgG: 96 well ELISA plates (Nunc, Life Technologies,
UK) were coated overnight at 4°C with DNP-BIg (10 µg/
ml) in hydrogen carbonate buffer (0.1 M Na HCO3, pH
8.5). SRBC: 96 well ELISA plates were coated with 10 µg/
ml poly-L-lysine (Sigma-Aldrich) in PBS for 30 minutes at
room temperature. The plates were then washed with PBS
and 50 µl freshly washed SRBC (2 × 106 cells/ml in PBS)
were added. The plates were centrifuged at 600 × g for 10
minutes and 50 µl 0.5% (v/v) glutaraldehyde (electron
microscopy grade, Sigma-Aldrich) in cold PBS were added
and left for 20 minutes at room temperature. After 3 wash-
ings with PBS, wells were blocked with 200 µl of 1% (w/
v) milk powder in 100 mM glycine (Sigma-Aldrich) for 30
minutes at room temperature. After 3 further washings in
PBS, 300 µl blocking buffer was added to the wells and the
plates were stored at -20°C until use.
ELISA detection protocols (both antigens)
The plates were thawed, washed twice with 200 µl of 0.5%
biotin free BSA (Sigma-Aldrich)-PBS and blocked with
200 µl of 0.5% biotin free BSA-PBS for 1 h at 37°C. Pre-
immune or test plasma was added at various dilutions,
and incubated for 2 h at 37°C. The plates were washed 4
times with PBS. IgM and IgG subclasses were detected
using mouse immunoglobulin isotype specific mono-
clonal antibodies : anti-IgM IgG2a,κ, PharMingen; anti-
IgG2a, IgG1,κ, PharMingen; anti-IgG2b, IgG2a,κ,
PharMingen; anti-IgG1, IgG1,κ, PharMingen; Binding was
detected using alkaline phosphatase conjugated streptavi-
din (Caltag Lab), diluted 1:2000 in 0.5% biotin free BSA-
PBS, and p-nitrophenyl phosphate (Sigma-Aldrich) pre-
pared according to the manufacture's guidelines. The
plates were developed at 37°C and absorbance read at
405 nm (ELISA plate reader, Revelation software) after
15–20 minutes.
ELISPOT
Spleen cells (1.2 × 106 per well) from mice immunised
with SRBC or unimmunised controls were cultured with
washed SRBC (4 × 105)in RPMI medium containing 5%
FCS for eight hours in ELISPOT plates precoated with anti-
IL-2 or anti-IL-4 antibody (eBiosciences, 5 µg/ml). Spleen
cells were lysed by washing in water, and then the spots
were developed using biotinylated anti-cytokine antibod-
ies (eBiosciences, 1 µg/ml) and streptavidin alkaline
phosphatase substrate as described in detail elsewhere
[40].
Electron microscopy of liver and spleen
Parts of liver and spleen samples obtained from chimaeric
and control mice were cut into small pieces and fixed in
2% paraformaldehyde-2% glutaraldehyde buffered with
0.1 M phosphate buffer for 24 hours. The samples were
postfixed with 2% OsO4, dehydrated with a graded series
of alcohol, and embedded in Epon 812. Ultrathin sections
were cut with an ultramicrotome (Ultracut N, Hitachi,
Japan), stained with uranyl acetate and lead citrate, and
observed with a Hitachi H7100 microscope.
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